NewEdge Advisors LLC Has $6.15 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

NewEdge Advisors LLC lifted its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.2% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,825 shares of the medical equipment provider’s stock after purchasing an additional 1,044 shares during the period. NewEdge Advisors LLC’s holdings in Intuitive Surgical were worth $6,150,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in ISRG. J. W. Coons Advisors LLC lifted its holdings in shares of Intuitive Surgical by 6.0% in the fourth quarter. J. W. Coons Advisors LLC now owns 1,170 shares of the medical equipment provider’s stock valued at $395,000 after purchasing an additional 66 shares in the last quarter. Jones Financial Companies Lllp lifted its stake in Intuitive Surgical by 1,100.0% during the 4th quarter. Jones Financial Companies Lllp now owns 432 shares of the medical equipment provider’s stock valued at $146,000 after acquiring an additional 396 shares in the last quarter. CWA Asset Management Group LLC boosted its holdings in Intuitive Surgical by 36.7% during the 4th quarter. CWA Asset Management Group LLC now owns 1,991 shares of the medical equipment provider’s stock worth $672,000 after acquiring an additional 534 shares during the last quarter. Lake Street Advisors Group LLC purchased a new position in Intuitive Surgical during the 4th quarter worth $487,000. Finally, Capital International Ltd. CA grew its stake in shares of Intuitive Surgical by 1.0% in the 4th quarter. Capital International Ltd. CA now owns 60,779 shares of the medical equipment provider’s stock worth $20,504,000 after acquiring an additional 589 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insiders Place Their Bets

In other Intuitive Surgical news, Director Craig H. Barratt sold 1,400 shares of Intuitive Surgical stock in a transaction that occurred on Tuesday, July 23rd. The stock was sold at an average price of $458.13, for a total transaction of $641,382.00. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. In related news, EVP Robert Desantis sold 1,413 shares of the business’s stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $438.60, for a total value of $619,741.80. Following the completion of the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at approximately $2,414,931.60. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Craig H. Barratt sold 1,400 shares of the company’s stock in a transaction on Tuesday, July 23rd. The shares were sold at an average price of $458.13, for a total value of $641,382.00. The disclosure for this sale can be found here. In the last ninety days, insiders sold 53,120 shares of company stock worth $25,528,753. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 1.3 %

Shares of ISRG stock opened at $484.76 on Wednesday. The firm has a market cap of $171.94 billion, a P/E ratio of 87.50, a price-to-earnings-growth ratio of 5.39 and a beta of 1.39. Intuitive Surgical, Inc. has a 12-month low of $254.85 and a 12-month high of $496.48. The business has a 50-day moving average price of $474.22 and a two-hundred day moving average price of $430.19.

Intuitive Surgical (NASDAQ:ISRG) last announced its quarterly earnings data on Thursday, July 18th. The medical equipment provider reported $1.78 earnings per share for the quarter, beating the consensus estimate of $1.54 by $0.24. The firm had revenue of $2.01 billion during the quarter, compared to the consensus estimate of $1.97 billion. Intuitive Surgical had a return on equity of 13.04% and a net margin of 27.65%. The business’s revenue was up 14.5% on a year-over-year basis. During the same quarter in the previous year, the company posted $1.18 earnings per share. As a group, research analysts expect that Intuitive Surgical, Inc. will post 5.22 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

ISRG has been the topic of several analyst reports. Robert W. Baird boosted their price target on shares of Intuitive Surgical from $487.00 to $503.00 and gave the stock an “outperform” rating in a report on Friday, July 19th. Redburn Atlantic raised shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the stock from $380.00 to $510.00 in a research report on Friday, August 2nd. Morgan Stanley increased their target price on shares of Intuitive Surgical from $375.00 to $460.00 and gave the company an “equal weight” rating in a research report on Monday, July 15th. Stifel Nicolaus lifted their price target on shares of Intuitive Surgical from $430.00 to $475.00 and gave the stock a “buy” rating in a report on Friday, July 19th. Finally, Barclays raised their target price on Intuitive Surgical from $430.00 to $490.00 and gave the stock an “overweight” rating in a research report on Thursday, July 18th. Six investment analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company’s stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $449.70.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.